The goal of this project is to investigate differential gene expression in the substantia nigra in order to generate candidate genes for Parkinson's Disease (PD), a heritable neurological disorder characterized by pathological degeneration of substantia nigra. The investigators hypothesize that degeneration is associated with an altered pattern of gene expression in this tissue; therefore, genes whose expression in this tissue is significantly up-or down-regulated in affected individuals constitute good candidate genes for PD and related disorders. Additional candidate genes will be identified as those genes that are expressed in the normal substantia nigra at a higher level than in other regions of normal human brains. Serial Analysis of Gene Expression (SAGE) is a powerful technique that allows quantitative determination of all transcripts present in a given tissue by cloning and sequencing large numbers of unique 13-base pair tags associated with each gene. Dr. Vance and his collaborators plan to use SAGE to compare the population of genes expressed in substantia nigra isolated from three different sources: normal control individuals, individuals affected with Lewy body positive PD, and individuals affected with FTDP, a Lewy body negative neurodegenerative disease also characterized by gliosis of the substantia nigra. This last group of samples will allow the investigators to control for the confounding effects of under-representation of neurons in the PD substantia nigra. Genes that are under- or over-expressed in the substantia nigra in the disease-state will be considered potential candidate genes, as will any genes expressed specifically in the normal substantia nigra. These candidate genes will be tested for association with PD in Project I using sub-based association analysis among patients with idiopathic PD as outlined in Project I. This double screen-differential expression in the appropriate tissues, as well as statistical association with disease-will be a very powerful mechanism for selecting candidate genes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS039764-02
Application #
6345022
Study Section
Special Emphasis Panel (ZNS1)
Project Start
2000-09-01
Project End
2001-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2000
Total Cost
$199,092
Indirect Cost
Name
Duke University
Department
Type
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Nuytemans, Karen; Maldonado, Lizmarie; Ali, Aleena et al. (2016) Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants. Neurol Genet 2:e44
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129

Showing the most recent 10 out of 114 publications